New York health officials confirmed Thursday that an unvaccinated adult in Rockland County has contracted polio, the first known U.S. case since 2013 and a rare reappearance of a disease eliminated from sustained domestic circulation more than four decades ago. The joint state and county alert said laboratory sequencing identified vaccine-derived poliovirus type 2 and that officials were investigating where and how transmission occurred.

The patient developed weakness and paralysis, according to local reporting, making the case clinically serious even though most poliovirus infections produce no symptoms. Health officials stressed that the immediate concern extends beyond one patient: because infected people can shed the virus without appearing ill, a paralytic case can be evidence of broader undetected transmission.

Rockland County opened vaccination clinics and urged anyone who is unvaccinated or incompletely vaccinated to receive the inactivated polio vaccine. The county's polio guidance emphasizes that vaccination is the principal defense and that people unsure of their status should consult a clinician.

A rare case exposes the consequences of vaccination gaps

Polio was once among the most feared childhood diseases in the United States, causing thousands of cases of paralysis each year before widespread vaccination. The last naturally occurring U.S. cases were recorded in 1979. Imported or vaccine-derived infections have occurred rarely since then, but the country has not had sustained endemic transmission.

The Rockland patient had not been vaccinated, according to the Washington Post. That detail is central because the inactivated vaccine used in the United States cannot cause polio and is highly effective at preventing paralytic disease. The challenge is maintaining sufficiently high coverage in every community so that an imported virus cannot find clusters of susceptible people.

Rockland County has faced lower vaccination uptake in some communities, a problem that became highly visible during the 2018-2019 measles outbreak. Polio creates an even more difficult surveillance problem because most infections are asymptomatic. A community can therefore have transmission for weeks before a person develops paralysis and triggers an investigation.

Sequencing points to a vaccine-derived virus

The New York State Department of Health said sequencing by its Wadsworth Center and confirmation by the Centers for Disease Control and Prevention identified a revertant Sabin type 2 virus. Oral polio vaccine, still used in some countries, contains weakened live virus. In rare circumstances, that virus can circulate long enough in under-immunized populations to genetically change and regain the ability to cause paralysis.

That does not mean the U.S. injectable vaccine caused the infection. The United States stopped routine use of oral polio vaccine in 2000 and relies on inactivated vaccine, which contains no live virus. STAT reported that the genetic finding strongly suggests a chain of transmission originating where oral vaccine is used, though investigators had not yet established the route by which the virus reached Rockland County.

The distinction matters for public understanding. Vaccine-derived poliovirus emerges when weakened vaccine virus circulates among inadequately immunized people; high vaccination coverage interrupts that circulation. The phenomenon therefore reflects insufficient immunity rather than a reason to avoid vaccination.

Public-health officials are searching for silent spread

The immediate investigation involves interviews, laboratory testing and efforts to determine whether close contacts or others in the community have been infected. Fox News reported that the patient was no longer considered contagious by the time the case was announced, shifting the concern toward earlier exposures and potential community transmission.

Poliovirus spreads mainly by the fecal-oral route and can also spread through respiratory secretions under some circumstances. Because asymptomatic people can transmit it, routine case-based surveillance may detect only a small fraction of infections. Health departments can supplement clinical testing with environmental surveillance, including wastewater sampling, if the investigation suggests community circulation.

CBS New York reported that officials were urging families to verify children's vaccination records and adults at higher risk to discuss vaccination with health professionals. The recommendation is especially urgent for people who are unvaccinated, because there is no antiviral treatment that reverses paralysis once poliovirus damages motor neurons.

The case is a warning, not evidence of a national resurgence

One confirmed infection does not by itself indicate widespread U.S. transmission. The country maintains high overall childhood vaccination coverage, and most Americans have protection from routine immunization. But national averages can conceal local pockets where coverage is much lower, allowing highly contagious diseases to reappear.

That is why the Rockland case matters beyond its rarity. State officials noted that the last known U.S. polio case was in 2013 and urged anyone who is unvaccinated or not up to date to be immunized. The message is straightforward: the virus has not changed the fundamental prevention strategy that eliminated domestic polio transmission in the first place.

The next phase of the investigation will determine whether the patient represents an isolated importation or the visible edge of a larger transmission chain. Until that is known, public-health authorities are treating the case as a reminder that eradication has not yet been achieved globally and that diseases suppressed by vaccination can return wherever immunity falls low enough to give them room to spread.